Pharmacodynamic Evaluation of PL2200 Versus Enteric-Coated and Immediate Release Aspirin in Diabetic Patients
Status:
Completed
Trial end date:
2012-06-01
Target enrollment:
Participant gender:
Summary
This study will determine if aspirin from PL2200, an investigational product, gets into the
blood stream as quickly as plain aspirin and enteric coated aspirin, and to test whether
PL2200 is able to prevent blood clots as effectively as these other products, when
administered to patients with diabetes.